What is Vaso-Meditech EECP Treatment? Is it an Approved Treatment?

Cardiovascular diseases are one of the major diseases affecting the global population, as well as one of the leading causes of mortality worldwide. With advancements in medical technology, new treatment options are emerging that offer less invasive and highly effective alternatives to traditional surgical procedures. One such innovative treatment is Enhanced External Counterpulsation (EECP). One of the options within EECP is the Vaso-Meditech treatment. It is important to understand this treatment, its mechanisms, benefits, and whether it is an approved treatment option.

EECP: A Basic Overview

Enhanced External Counterpulsation (EECP) is a non-invasive treatment designed to improve blood flow to the heart. It is primarily used for patients with chronic angina and heart failure. EECP therapy involves the use of inflatable cuffs wrapped around the patient's legs and buttocks. These cuffs inflate and deflate in sync with the cardiac cycle, enhancing venous return to the heart and subsequently improving coronary blood flow.

What is Vaso-Meditech EECP Treatment?

Vaso-Meditech EECP treatment is a specific type of EECP therapy provided by Vaso-Meditech Pvt Ltd, a company specialising in non-invasive cardiovascular treatments. This therapy utilises advanced technology to deliver consistent and effective treatment sessions that can significantly improve a patient’s quality of life.

How Does It Work?

The treatment involves the patient lying on a comfortable treatment table while wearing a series of cuffs around their calves, thighs, and buttocks. These cuffs are connected to an EECP machine, which inflates and deflates them in sync with the patient’s heartbeat. The timing of inflation and deflation is crucial as it enhances blood flow back to the heart during diastole (the heart's relaxation phase) and reduces the workload on the heart during systole (the contraction phase).

 

Mechanism of Action

1.    Enhanced Blood Flow: The sequential inflation of the cuffs increases venous return to the heart, thereby improving coronary perfusion.

2.    Collateral Circulation: Over time, EECP therapy can promote the development of new blood vessels (collaterals) in the heart, which improves overall blood flow and reduces symptoms of angina.

3.    Reduced Cardiac Workload: By decreasing the afterload, EECP helps to reduce the heart's workload, allowing it to pump more efficiently.

Benefits of EECP Therapy

Non-Invasive

One of the primary benefits of Vaso-Meditech EECP treatment is that it is completely non-invasive. This means there are no surgical risks involved, making it a safer option for patients who might be at high risk for surgery.

Improved Quality of Life

Studies have shown that patients undergoing EECP therapy often experience significant improvement in symptoms of angina and heart failure. This leads to a better quality of life, with increased ability to perform daily activities without discomfort.

Long-Term Efficacy

EECP has been shown to provide long-term benefits. Many patients experience sustained relief from symptoms even years after completing the treatment course.

Safety and Tolerability

EECP therapy is well-tolerated by most patients, with minimal side effects. Common side effects, if any, are usually mild and include skin irritation or discomfort due to the cuffs.

Is Vaso-Meditech EECP an Approved Treatment?

FDA Approval

Yes, EECP therapy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic stable angina and heart failure. The FDA approval is a testament to the efficacy and safety of the treatment.

Clinical Guidelines

Several clinical guidelines recommend EECP therapy as an adjunctive treatment for patients with refractory angina who are not suitable candidates for invasive procedures like angioplasty or bypass surgery. The American College of Cardiology (ACC) and the American Heart Association (AHA) have acknowledged the benefits of EECP in their guidelines.

Global Acceptance

Beyond the United States, EECP therapy is widely accepted and utilised in many countries around the world, including India. It is recognised by numerous healthcare institutions and cardiology societies for its effectiveness in managing coronary artery disease and heart failure.

Improve The Heart’sHealth The Non-Invasive Way

Vaso-Meditech EECP treatment represents a significant advancement in the non-invasive management of heart disease. Approved by the FDA and supported by clinical guidelines, EECP therapy offers a safe, effective, and well-tolerated option for patients suffering from chronic angina and heart failure. At Heal Your Heart Clinic in Chennai, they specialise in providing this advanced therapy, ensuring their patients receive the best possible care tailored to their needs. Patients take a crucial step towards improving their heart health and overall quality of life by choosing Vaso-Meditech EECP treatment.